Mild hypoglycaemic attacks induced by sulphonylureas related to CYP2C9, CYP2C19 and CYP2C8 polymorphisms in routine clinical setting. (Q50263760)

28 February 2018

title

Mild hypoglycaemic attacks induced by sulphonylureas related to CYP2C9, CYP2C19 and CYP2C8 polymorphisms in routine clinical setting. (English)

1 reference

28 February 2018

author

Erkan Cure

4

1 reference

28 February 2018

author name string

Osman Gökalp

1

1 reference

28 February 2018

Arzu Gunes

2

1 reference

28 February 2018

Hakan Cam

3

1 reference

28 February 2018

Osman Aydın

5

1 reference

28 February 2018

Mehmet Numan Tamer

6

1 reference

28 February 2018

Maria Gabriella Scordo

7

1 reference

28 February 2018

Marja-Liisa Dahl

8

1 reference

28 February 2018

publication date

21 June 2011

1 reference

28 February 2018

European Journal of Clinical Pharmacology

published in

1 reference

28 February 2018

volume

67

1 reference

28 February 2018

page(s)

1223-1229

1 reference

28 February 2018

issue

12

1 reference

28 February 2018

https://scigraph.springernature.com/pub.10.1007/s00228-011-1078-4

exact match

0 references

cites work

Risk of Hypoglycaemia with Oral Antidiabetic Agents in Patients with Type 2 Diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1078-4

Effect of genetic polymorphisms in cytochrome p450 (CYP) 2C9 and CYP2C8 on the pharmacokinetics of oral antidiabetic drugs: clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1078-4

Identification of the human cytochromes P450 catalysing the rate-limiting pathways of gliclazide elimination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1078-4

The effects of CYP2C9 and CYP2C19 genetic polymorphisms on the pharmacokinetics and pharmacodynamics of glipizide in Chinese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1078-4

Cytochrome P450 2C9 polymorphisms: a comprehensive review of the in-vitro and human data.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1078-4

Presence of CYP2C9*3 allele increases risk for hypoglycemia in Type 2 diabetic patients treated with sulfonylureas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1078-4

Association between CYP2C9 slow metabolizer genotypes and severe hypoglycaemia on medication with sulphonylurea hypoglycaemic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1078-4

Severe sulfonylurea-induced hypoglycemia: a problem of uncritical prescription and deficiencies of diabetes care in geriatric patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1078-4

Cytochrome P450 2C9 *2 and *3 polymorphisms and the dose and effect of sulfonylurea in type II diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1078-4

Clinical significance of the cytochrome P450 2C19 genetic polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1078-4

A common novel CYP2C19 gene variant causes ultrarapid drug metabolism relevant for the drug response to proton pump inhibitors and antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1078-4

Need for reassessment of reported CYP2C19 allele frequencies in various populations in view of CYP2C19*17 discovery: the case of Greece.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1078-4

Influence of CYP2C9 and CYP2C19 genetic polymorphisms on pharmacokinetics and pharmacodynamics of gliclazide in healthy Chinese Han volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1078-4

Influence of CYP2C9 and CYP2C19 genetic polymorphisms on pharmacokinetics of gliclazide MR in Chinese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1078-4

Polymorphisms in human CYP2C8 decrease metabolism of the anticancer drug paclitaxel and arachidonic acid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1078-4

Polymorphism in CYP2C8 is associated with reduced plasma concentrations of repaglinide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1078-4

Trimethoprim and the CYP2C8*3 allele have opposite effects on the pharmacokinetics of pioglitazone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1078-4

Linkage between the CYP2C8 and CYP2C9 genetic polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1078-4

Effects of St John's wort and CYP2C9 genotype on the pharmacokinetics and pharmacodynamics of gliclazide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1078-4

Pharmacokinetics of glimepiride and cytochrome P450 2C9 genetic polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1078-4

Glyburide and glimepiride pharmacokinetics in subjects with different CYP2C9 genotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1078-4

Pharmacokinetics of chlorpheniramine, phenytoin, glipizide and nifedipine in an individual homozygous for the CYP2C9*3 allele

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1078-4

Effect of the CYP2C8 Genotype on the Pharmacokinetics and Pharmacodynamics of Repaglinide

21 January 2018

1 reference

12 December 2020

Glibenclamide-associated hypoglycaemia: a report on 57 cases

1 reference

12 December 2020

Influence of SLCO1B1 and CYP2C8 gene polymorphisms on rosiglitazone pharmacokinetics in healthy volunteers

1 reference

12 December 2020

Validation of methods for CYP2C9 genotyping: frequencies of mutant alleles in a Swedish population.

1 reference

12 December 2020

CYP2C8 polymorphisms in Caucasians and their relationship with paclitaxel 6α-hydroxylase activity in human liver microsomes

1 reference

12 December 2020

10.1007/S00228-011-1078-4

Identifiers

DOI

1 reference

28 February 2018

PubMed ID

21691805

1 reference

28 February 2018